Will Ebiefung

About the Author Will Ebiefung

Will Ebiefung studied finance and accounting at the University of Tennesee. He works as a freelance investment analyst focusing on equities with market caps below $100 million. In addition to writing, Will is a full-time investor focusing on web properties and debt-based securities.

The Relationship Between DryShips Inc. (DRYS) and Kalani Seems Legit

There is new information about Kalani Investments Limited, the mysterious investor DryShips Inc. (NASDAQ:DRYS) uses to dilute its shareholders.

DryShips Inc. (DRYS): A Natural-Born Capital Killer

DryShips Inc. (NASDAQ:DRYS) released this week a statement announcing the continuation of its dividend policy with a $2.

DryShips Inc. (DRYS): Dealing with the Devil

DryShips Inc. (NASDAQ:DRYS) soars over 200% to $1.

Tesla Inc (TSLA): A Bubble or Opportunity of a Lifetime?

With shares trading for over $300 apiece, Tesla Inc (NASDAQ:TSLA) recently surpassed Ford to become the second-largest American automaker by market cap, second …

DryShips Inc. (DRYS): Fool Me Once, Shame on You – But Fool Me Twice?

As the old saying goes, fool me once, shame on you, but fool me twice shame on me. Nowhere is this saying more …

What Can Valeant Pharmaceuticals Intl Inc (VRX) Do to Get out of This Mess?

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) continues its freefall, breaking below $10 for the first time in over a decade. This latest drop comes …

DryShips Inc. (DRYS): Will The Dilution Ever End?

This news shouldn’t surprise anyone familiar with DryShips Inc. (NASDAQ:DRYS) and its unorthodox CEO, Georgie Economou: DryShips has once again diluted shareholders.

Valeant Pharmaceuticals Intl Inc (VRX): Weak Growth Drivers, No Room for R&D

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) turnaround story depends on transforming from an acquisition-based ‘platform’ company into an R&D-driven traditional drug company. A conventional …

DryShips Inc. (DRYS): Four Acquisitions, Strong Baltic Dry Index, and Sector Momentum

George Economou has announced several additions to the DryShips Inc. (NASDAQ:DRYS) fleet in the form of four Newcastlemax dry bulk transport vessels.

How Should Investors Value Valeant Pharmaceuticals Intl Inc (VRX)?

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock has lost over 25% in 2017 alone. Yet, is the struggling pharmaceutical giant undervalued or still overvalued at …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts